624727-99-7

Upstream product

• 164514-49-2 3-phenyl-4-N-phenylamino-1-(2,3,5-tri-O-benzoyl-α-L-lyxofuranosyl)pyrazolo[3,4-d]pyrimidine 
• 164514-25-4 (2S,3S,4R,5R)-2-Hydroxymethyl-5-(3-phenyl-4-phenylamino-pyrazolo[3,4-d]pyrimidin-1-yl)-tetrahydro-furan-3,4-diol 
• 22249-17-8 1-O-acetyl-2,3,5-tri-O-benzoyl-L-lyxofuranose 
• 202119-57-1 methyl L-lyxofuranoside 
• 169529-25-3 1-O-methyl-2,3,5-tri-O-benzoyl-L-lyxofuranose 
• 124-63-0 methanesulfonyl chloride 
• 624727-98-6 3-phenyl-4-N-phenylamino-1-(2,3-O-isopropylidene-α-L-lyxofuranosyl)pyrazolo[3,4-d]pyrimidine 

Downstream Products

• 624728-00-3 4-N-phenylamino-3-phenyl-1-(5-amino-5-deoxy-2,3-O-isopropylidene-α-L-lyxofuranosyl)pyrazolo[3,4-d]pyrimidine 

Relevant academic research and scientific papers

Adenosine Kinase Inhibitors. 3. Synthesis, SAR, and Antiinflammatory Activity of a Series of L-Lyxofuranosyl Nucleosides

Chronic inflammatory diseases, such as arthritis and rheumatoid arthritis, remain major health problems worldwide. We previously demonstrated that adenosine kinase inhibitors (AKIs) exhibit antiinflammatory effects by inhibiting TNF-α production, neutroph